ROIV's three largest insider shareholders as of May 30, 2026 are Pharma Technologies Ltd. Dexcel (TenPercentOwner, 102.85Mn shares), Investments (Uk) Ltd Svf (TenPercentOwner, 73.03Mn shares), Chemical Co., Ltd. Sumitomo (TenPercentOwner, 71.25Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Global Investors Lp Viking | - | 0 | 12,884,307 | 26 Jun, 2023 |
| Global Performance Llc Viking | - | 0 | 12,884,307 | 26 Jun, 2023 |
| James C Momtazee | - | 109,405 | 0 | 21 Apr, 2026 |
| Keith S Manchester | - | 0 | 28,010,344 | 14 Nov, 2022 |
| Financial Lp Qvt | - | 0 | 65,178,939 | 02 Oct, 2023 |
| Meghan Fitzgerald | - | 42,963 | 0 | 30 Mar, 2026 |
| Vivek Ramaswamy | - | 33,653,755 | 0 | 15 Dec, 2025 |
| Ilan Oren | - | 120,229 | 0 | 21 Apr, 2026 |
| Frank Torti | President And Vant Chair | 13,576,512 | 0 | 02 Apr, 2026 |
| Andrew Lo | - | 52,142 | 0 | 19 Sep, 2022 |
| Investments (Uk) Ltd Svf | - | 0 | 73,031,667 | 02 Oct, 2023 |
| Pharma Technologies Ltd. Dexcel | - | 102,849,443 | 0 | 14 Nov, 2022 |
| Mayukh Sukhatme | President Cio | 18,677,617 | 0 | 01 Apr, 2026 |
| Matthew Gline | Ceo | 16,736,116 | 0 | 20 Apr, 2026 |
| Chemical Co., Ltd. Sumitomo | - | 0 | 71,251,083 | 26 Jun, 2023 |
| Melissa B, Epperly | - | 15,804 | 0 | 18 Mar, 2026 |
| Daniel Allen Gold | - | 0 | 66,664,336 | 07 Mar, 2024 |
| Rakhi Kumar | Chief Accounting Officer | 162,306 | 0 | 24 Feb, 2025 |
| Richard Pulik | Cfo | 297,511 | 0 | 22 Apr, 2026 |
| Jennifer Humes | Chief Accounting Officer | 113,364 | 0 | 22 Apr, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 20 Apr, 2026 | Richard Pulik | Common Shares | A | 60,644 | $0.00 | 297,511 | D | A |
| 20 Apr, 2026 | Jennifer Humes | Common Shares | A | 29,173 | $0.00 | 113,364 | D | A |
| 20 Apr, 2026 | Richard Pulik | Stock Option (Right to Buy) | A | 84,026 | $0.00 | 84,026 | D | A |
| 20 Apr, 2026 | Jennifer Humes | Stock Option (Right to Buy) | A | 27,157 | $0.00 | 27,157 | D | A |
| 17 Apr, 2026 | Ilan Oren | Common Shares | A | 896 | $0.00 | 120,324 | D | A |
| 17 Apr, 2026 | James C Momtazee | Common Shares | A | 469 | $0.00 | 109,499 | D | A |
| 17 Apr, 2026 | James C Momtazee | Common Shares | D | 94 | $29.83 | 109,405 | D | F |
| 17 Apr, 2026 | Ilan Oren | Common Shares | D | 95 | $29.83 | 120,229 | D | F |
| 16 Apr, 2026 | Matthew Gline | Common Shares | D | 289,774 | $29.16 | 16,736,116 | D | S |
| 31 Mar, 2026 | Frank Torti | Common Shares | D | 160,035 | $27.70 | 13,576,512 | D | F |
| 30 Mar, 2026 | Mayukh Sukhatme | Common Shares | A | 58,391 | - | 18,894,938 | D | M |
| 30 Mar, 2026 | Mayukh Sukhatme | Common Shares | A | 58,391 | - | 18,894,938 | D | M |
| 30 Mar, 2026 | Matthew Gline | Common Shares | A | 97,319 | - | 17,384,400 | D | M |
| 30 Mar, 2026 | Mayukh Sukhatme | Common Shares | A | 58,391 | - | 18,894,938 | D | M |
| 30 Mar, 2026 | Mayukh Sukhatme | Common Shares | A | 58,391 | - | 18,894,938 | D | M |
| 30 Mar, 2026 | Mayukh Sukhatme | Common Shares | A | 58,391 | - | 18,894,938 | D | M |
| 30 Mar, 2026 | Mayukh Sukhatme | Common Shares | D | 29,809 | $26.41 | 18,865,129 | D | F |
| 30 Mar, 2026 | Mayukh Sukhatme | Common Shares | D | 29,809 | $26.41 | 18,865,129 | D | F |
| 30 Mar, 2026 | Mayukh Sukhatme | Common Shares | D | 29,809 | $26.41 | 18,865,129 | D | F |
| 30 Mar, 2026 | Mayukh Sukhatme | Common Shares | D | 29,809 | $26.41 | 18,865,129 | D | F |